Sagimet Biosciences Inc.
SGMT
$7.11
-$0.24-3.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 2.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 2.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 0.00 | 2.00M |
| SG&A Expenses | 17.43M | 17.03M | 16.01M | 15.84M | 16.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.89M | 65.55M | 54.45M | 45.73M | 38.28M |
| Operating Income | -66.89M | -65.55M | -54.45M | -45.73M | -36.28M |
| Income Before Tax | -59.38M | -57.11M | -45.57M | -37.52M | -29.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.38 | -57.11 | -45.57 | -37.52 | -29.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.38M | -57.11M | -45.57M | -37.52M | -29.25M |
| EBIT | -66.89M | -65.55M | -54.45M | -45.73M | -36.28M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.85 | -1.78 | -1.44 | -1.29 | -1.18 |
| Normalized Basic EPS | -1.15 | -1.11 | -0.90 | -0.80 | -0.74 |
| EPS Diluted | -1.85 | -1.78 | -1.44 | -1.29 | -1.18 |
| Normalized Diluted EPS | -1.15 | -1.11 | -0.90 | -0.80 | -0.74 |
| Average Basic Shares Outstanding | 128.73M | 128.45M | 125.29M | 116.54M | 102.59M |
| Average Diluted Shares Outstanding | 128.73M | 128.45M | 125.29M | 116.54M | 102.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |